David Sánchez‐Martín

Tumor Immunotherapy Using Gene-Modified Human Mesenchymal Stem Cells Loaded into Synthetic Extracellular Matrix Scaffolds

Marta Compte, Ángel M. Cuesta, David Sánchez‐Martín et al. · Stem Cells · 2008 · 96 citations · Full text

Tissue Engineering, Cell Therapy, Engineering +20

Long-term in vivo imaging of human angiogenesis: Critical role of bone marrow-derived mesenchymal stem cells for the generation of durable blood vessels

Laura Sanz, Patricia Santos-Valle, Vanesa Alonso-Camino et al. · Microvascular Research · 2008 · 80 citations

Tissue Engineering, Regenerative Medicine, Durable Blood Vessels +12

In Vivo Tumor Targeting and Imaging with Engineered Trivalent Antibody Fragments Containing Collagen-Derived Sequences

Ángel M. Cuesta, David Sánchez‐Martín, Laura Sanz et al. · PLoS ONE · 2009 · 56 citations · Full text

The Multicompartmental p32/gClqR as a New Target for Antibody-based Tumor Targeting Strategies

David Sánchez‐Martín, Ángel M. Cuesta, Valentina Fogal et al. · Journal of Biological Chemistry · 2010 · 41 citations · Full text

Immunology, Immunotherapy, Tumor Biology +16

Proteasome activator complex PA28 identified as an accessible target in prostate cancer by in vivo selection of human antibodies

David Sánchez‐Martín, Jorge L. Martínez‐Torrecuadrada, Tambet Teesalu et al. · Proceedings of the National Academy of Sciences · 2013 · 39 citations · Full text

Immunology, Proteasome, Vivo Selection +21